Cliniphar Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Revenue	3,700	3,585	3,526
Revenue Growth (YoY)	3.21%	1.67%	-
Cost of Revenue	3,057	2,920	2,852
Gross Profit	643	665	674
Selling, General & Admin	509	517	506
Operating Expenses	509	526	513
Operating Income	134	139	161
Interest Expense	-8	-6	-6
Interest & Investment Income	32	14	2
Currency Exchange Gain (Loss)	2	1	2
Other Non Operating Income (Expenses)	-6	25	5
EBT Excluding Unusual Items	154	173	164
Gain (Loss) on Sale of Investments	-4	6	-548
Gain (Loss) on Sale of Assets	-3	19	-
Asset Writedown	-	-	-3
Other Unusual Items	-	-	-162
Pretax Income	147	198	-549
Income Tax Expense	-14	8	64
Net Income	161	190	-613
Net Income to Common	161	190	-613
Net Income Growth	-15.26%	-	-
Shares Outstanding (Basic)	1	1	1
Shares Outstanding (Diluted)	1	1	1
EPS (Basic)	161.00	190.00	-613.00
EPS (Diluted)	161.00	190.00	-613.00
EPS Growth	-15.26%	-	-
Free Cash Flow	269	-	-
Free Cash Flow Per Share	269.00	-	-
Gross Margin	17.38%	18.55%	19.11%
Operating Margin	3.62%	3.88%	4.57%
Profit Margin	4.35%	5.30%	-17.39%
Free Cash Flow Margin	7.27%	-	-
EBITDA	166	-	-
EBITDA Margin	4.49%	-	-
D&A For EBITDA	32	-	-
EBIT	134	139	161
EBIT Margin	3.62%	3.88%	4.57%
Effective Tax Rate	-	4.04%	-